To explore the application of the K.A.R.T.® (KLSMC Articular Regeneration Technology) protocol—originally developed for the knee joint—for the treatment of osteochondral lesions of the talus (OLTs) in the ankle, using autologous peripheral blood-derived cells and hyaluronic acid, without requiring bone grafts.
This case series demonstrates that the K.A.R.T.® approach, using autologous peripheral blood-derived cells and hyaluronic acid, may offer a promising alternative to more invasive surgical options such as bone grafting, OATS, MACI, or joint replacement. The regenerative outcomes suggest the potential to delay or avoid joint degeneration and preserve ankle function in patients with osteochondral lesions of the talus.